Single-molecule analysis reveals that DNA replication

Scientists have used single-molecule analysis of DNA replication of basic cellular processes, which may provide a mechanism for DNA replication insights and to clarify the usefulness of such high-resolution studies.

090819104733181.gif

 
In the DNA replication period, a large group of proteins and enzymes to double-helix unwinding, and to synthesize the parent chain, a new complementary DNA chain. DNA synthesis is a continuous movement by a fork guide, the two branches - are known as the leading chain and post with the chain - by adding to the spiral structure. This group is called replication protein bodies, together with DNA polymerase, which is the nucleotide added to the chain and post-pilot with the chain, the two chains simultaneously synthesized.

In real-time experiment, Mike O'Donnell and his colleagues analyzed the DNA replication in E. coli replisome during the campaign, which enable them to study both the rate of DNA replication, but also study of polymerase continuity (continuity of measurement is the fact that DNA enzyme before leaving the number of nucleotides added to the chain of being copied). This group of authors say, although the latter increased significantly with the chain of synthetic replication continuity of body, which reduces the replication fork replication rate of the overall process.

Human sperm has a unique DNA signature

During the haploid phase of mammalian spermatogenesis, nucleosomal chromatin is ultimately repackaged by small, highly basic protamines to generate an extremely compact, toroidal chromatin architecture that is critical to normal spermatozoal function. In common with several species, however, the human spermatozoon retains a small proportion of its chromatin packaged in nucleosomes. As nucleosomal chromatin in spermatozoa is structurally more open than protamine-packaged chromatin, we considered it likely to be more accessible to exogenously applied endonucleases. Accordingly, we have used this premise to identify a population of endonuclease-sensitive DNA sequences in human and murine spermatozoa. Our results show unequivocally that, in contrast to the endonuclease-resistant sperm chromatin packaged by protamines, regions of increased endonuclease sensitivity are closely associated with gene regulatory regions, including many promoter sequences and sequences recognized by CCCTC-binding factor (CTCF). Similar differential packaging of promoters is observed in the spermatozoal chromatin of both mouse and man. These observations imply the existence of epigenetic marks that distinguish gene regulatory regions in male germ cells and prevent their repackaging by protamines during spermiogenesis. The ontology of genes under the control of endonuclease-sensitive regulatory regions implies a role for this phenomenon in subsequent embryonic development.

090830082071701_20091115134447.jpg

 

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

Cdk2 and cdk1 are individually dispensable for cell-cycle progression in cancer cell lines because they are able to compensate for one another. However, shRNA-mediated depletion of cdk1 alone or small molecule cdk1 inhibition abrogated S phase cell-cycle arrest and the phosphorylation of a subset of ATR/ATM targets after DNA damage. Loss of DNA damage-induced checkpoint control was caused by a reduction in formation of BRCA1-containing foci. Mutation of BRCA1 at S1497 and S1189/S1191 resulted in loss of cdk1-mediated phosphorylation and also compromised formation of BRCA1-containing foci. Abrogation of checkpoint control after cdk1depletion or inhibition in non-small-cell lung cancer cells sensitized them to DNA-damaging agents. Conversely, reduced cdk1 activity caused more potent G2/M arrest in nontransformed cells and antagonized the response to subsequent DNA damage. Cdk1 inhibition may therefore selectively sensitize BRCA1-proficient cancer cells to DNA-damaging treatments by disrupting BRCA1 function.

Adipose-derived stem cells to kill tumor

Cancer Institute of the Slovak Academy of Sciences, researchers have recently succeeded in extracting from human adipose tissue-derived mesenchymal stem cells out of (mesenchymal stem cells), and through genetic engineering approaches to synthesis, secretion, and destruction of tumor-oriented "suicide genes." Such gene therapy can be offensive to evade current detection techniques, treatment of small tumors to migrate objects. 
        Project Leader Dr. Cestmir Altaner said that these fat-derived stem cells are expected to be used for cell-based personalized treatment. Everyone more or less some of the excess fat, fat tissue may become a source of cells required for the treatment of cancer.

        Mesenchymal stem cells, by updating the cell to repair damaged tissues and organs. The researchers found that in a mixture of solid tumor cancer cell is prepared to base the development of normal cells have mesenchymal stem cells, speculated that the mesenchymal stem cells in tumors will be treated as damaged organs to migrate to the tumor, it can be used to find the original tumors and small metastases. These stem cells have a certain degree of plasticity, which can be organized according to the specialized micro-environment.

        Extracted from human adipose tissue-derived mesenchymal stem cells, researchers have begun to search for a treatment of colon cancer compared with standard chemotherapy agent 5-fluorouracil (5-FU) toxicity to normal cells in a smaller way. They will be mesenchymal stem cells in the culture medium in a large number of amplified, and then use a retrovirus vector cytosine deaminase (cytosine deaminase, CD) gene was inserted into the genome of cells, stem cells, the gene will be a poison fewer side effects the drug 5-fluorocytosine (5-FC) into 5-FU. Then, the researchers used chemotherapy to kill cancer, resulting in a fatal bystander effect (by-stander effect, refers to the killing of tumor cells missiles, targeting tumor cells in the concentration camps, give anti-personnel, but also can kill a tumor adjacent areas of tumor cells).

        In the transplantation of human colon cancer in nude mice (no immunity), the researchers genetically engineered to be the first injection of mesenchymal stem cells, then injected 5-FC. The results showed that tumor growth inhibition rate reached 68.5%, no toxic side effects occurred in mice 1. The researchers said that although there is no one mice were completely cured, but our program is very effective, even only once stem cells. Obviously, repeated treatments with better results.

        Common mesenchymal stem cells have a variety of sources (such as bone marrow), but the original production did not get more than fat tissue. The easiest way is to remove the tumor from surgery to get fat tissue, liposuction method can also be used to separate mesenchymal stem cells, these two processes to collect than bone marrow from the patient much easier. (Cancer Institute of the Slovak Academy of Sciences, researchers recently succeeded in extracting from human adipose tissue-derived mesenchymal stem cells out of (mesenchymal stem cells), and through genetic engineering approaches to synthesis, secretion, and destruction of tumor-oriented "suicide genes." This is kinds of gene therapy can be offensive to evade the current detection techniques, treatment of small tumors to migrate objects. the details published in the July 1 "Cancer Research" journal.

        Project Leader Dr. Cestmir Altaner said that these fat-derived stem cells are expected to be used for cell-based personalized treatment. Everyone more or less some of the excess fat, fat tissue may become a source of cells required for the treatment of cancer.

        Mesenchymal stem cells, by updating the cell to repair damaged tissues and organs. The researchers found that in a mixture of solid tumor cancer cell is prepared to base the development of normal cells have mesenchymal stem cells, speculated that the mesenchymal stem cells in tumors will be treated as damaged organs to migrate to the tumor, it can be used to find the original tumors and small metastases. These stem cells have a certain degree of plasticity, which can be organized according to the specialized micro-environment.

        Extracted from human adipose tissue-derived mesenchymal stem cells, researchers have begun to search for a treatment of colon cancer compared with standard chemotherapy agent 5-fluorouracil (5-FU) toxicity to normal cells in a smaller way. They will be mesenchymal stem cells in the culture medium in a large number of amplified, and then use a retrovirus vector cytosine deaminase (cytosine deaminase, CD) gene was inserted into the genome of cells, stem cells, the gene will be a poison fewer side effects the drug 5-fluorocytosine (5-FC) into 5-FU. Then, the researchers used chemotherapy to kill cancer, resulting in a fatal bystander effect (by-stander effect, refers to the killing of tumor cells missiles, targeting tumor cells in the concentration camps, give anti-personnel, but also can kill a tumor adjacent areas of tumor cells).

        In the transplantation of human colon cancer in nude mice (no immunity), the researchers genetically engineered to be the first injection of mesenchymal stem cells, then injected 5-FC. The results showed that tumor growth inhibition rate reached 68.5%, no toxic side effects occurred in mice 1. The researchers said that although there is no one mice were completely cured, but our program is very effective, even only once stem cells. Obviously, repeated treatments with better results.

        Common mesenchymal stem cells have a variety of sources (such as bone marrow), but the original production did not get more than fat tissue. The easiest way is to remove the tumor from surgery to get fat tissue, liposuction method can also be used to separate mesenchymal stem cells, these two processes to collect than bone marrow from the patient much easier.

How the evolution of increase in infectious virus

"Science" magazine reports that a new study could help researchers predict the influenza virus specific molecular changes in how we can help to overcome the virus of influenza vaccines and cause disease outbreaks. We do not infect humans, these strains of virus information (people are vaccinated on the existence of a large number of differences that make that they can not conduct controlled experiments), but scientists are now collected in a small horse in comparison with people information. These findings could help researchers design the most effective vaccination strategy to keep pace with the speed the evolution of influenza viruses. Since the 1960s, people have begun to use the horse flu vaccine, especially in the race horse in the.

090830082071701_20091115133555.jpg

 Andrew W. Park and his colleagues infected with different strains of equine influenza virus, the vaccinated and "as controls" mini horses were studied. The researchers of the virus hemagglutinin protein (which is the virus to evade the host immune system, the main method) in the amino acid changes have been followed up, and shows how changes in these amino acids affect the spread of the disease in the population ability. When infected with the virus and vaccine strains of virus strain differences emerged when a small horse the chance of infection, as well as the opportunity to become infectious will increase, while the infectious period of time will increase. The researchers reported that, however, even if the vaccine is still not perfect match to the host is good, because the increase in the proportion of vaccinated people can be offset by adverse effects on match, especially when vaccine and antiviral drugs, when used in conjunction.
adsense1
Categories
adsense2
Latest articles
Recent Comments
Monthly
Recent Trackbacks
Search
RSS链接
Links
Powered By FC2博客

马上开始博客吧!!

Powered By FC2博客

加为好友

和此人成为好友